eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank

3/2018
vol. 43
 
Share:
Share:
more
 
 
abstract:
Review paper

A fresh look at angiogenesis in juvenile idiopathic arthritis

Joanna Świdrowska-Jaros, Elżbieta Smolewska

(Centr Eur J Immunol 2018; 43 (3): 325-330)
Online publish date: 2018/10/30
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Angiogenesis is the complex process of creating new capillaries from preexisting blood vessels due to hypoxemia, injury or inflammation of the tissues. Numerous cytokines and cell mediators have been identified to induce and stimulate angiogenesis, but vascular endothelial growth factor (VEGF) is a key regulator. The role of proangiogenic factors in the pathogenesis of chronic arthritis is currently a subject of intensive investigations in adult patients with rheumatoid arthritis (RA) and, to a limited extent, in children with juvenile idiopathic arthritis (JIA). Recent studies has shown a significant correlation between proangiogenic marker concentrations and the severity of inflammation in either RA or JIA patients. The serum neovascularization markers correlate with the power Doppler ultrasound image of the inflamed joint and hypertrophic synovium, which may be connected with the disease activity.

The aim of this paper is to describe the state of the art on the important role of angiogenesis in adult and childhood rheumatoid arthritis.
keywords:

angiogenesis, juvenile idiopathic arthritis, rheumatoid arthritis, ultrasound

references:
Schrieber L, Jackson JC (1988): Angiogenesis in rheumatoid arthritis. In HJ Klippel, PA Dieppe (eds.). Rheumatology. Vol. 1. 2nd ed. Mosby, London, UK; 1-12.
Ferrara N, Alitalo K (1995): Clinical applications of angiogenic growth factors and their inhibitors. Nat Med 5: 1359-1364.
Taylor PC, Sivakumar B (2005): Hypoxia and angiogenesis in rheumatoid arthritis. Curr Opin Rheumatol 17: 293-298.
Mizia-Malarz A, Sobol G, Woś H (2008): Angiogeneza w przewlekłych schorzeniach zapalnych i nowotworowych. Pol Merk Lek 24: 185-189.
Zielonka TM (2003): Angiogeneza. Część I. Mechanizm powstawania nowych naczyń krwionośnych. Alergia Astma Immunologia 8: 169-174.
Kurzyk A (2015): Angiogeneza – możliwości, problemy, perspektywy. Postepy Biochem 61: 25-34.
Cierniewski CS (2006): Regulacja angiogenezy – nowa broń w onkologii. Biol Molek 1: 20-22.
Prakken B, Albani S, Martini A (2011): Juvenile idiopathic arthritis. Lancet 377: 2138-2149.
Ravelli A, Martini A (2007): Juvenile idiopathic arthritis. Lancet 369: 767-778.
Rutkowska-Sak L (2014): Młodzieńcze idiopatyczne zapalenie stawów – nie tylko nowości. Termedia, Poznań; 11-14.
Correll CK, Binstadt BA (2014): Advances in the pathogenesis and treatment of systemic juvenile idiopathic arthritis. Pediatr Res 75: 176-183.
Postepski J, Opoka-Winiarska V, Koziol-Montewka M, et al. (2003): Role of Mycoplasma pneumoniae infection in aetiopathogenesis of juvenile idiopathic arthritis. Med Wieku Rozwoj 7: 271-277.
Barash J, Goldzweig O (2007): Possible role of streptococcal infection in flares of juvenile idiopathic arthritis. Arthritis Rheum 57: 877-880.
Angelini F, Cancrini C, Colavita M, et al. (2003): Role of parvovirus B19 infection in juvenile chronic arthritis. Is more investigation needed? Clin Exp Rheum 21: 684.
Roupe van der Voort C, Heijnen CJ, Wulffraat N, et al. (2000): Stress induces increases in IL-6 production by leucocytes of patients with the chronic inflammatory disease juvenile rheumatoid arthritis: role of putative alpha (1) – adrenergic receptors. J Neuroimmunol 110: 223-229.
Berkun Y, Padeh S (2010): Environmental factors and the geo-epidemiology of juvenile idiopathic arthritis. Autoimmun Rev 9: 319-324.
Prahalad S (2004): Genetics of juvenile idiopathic arthritis: an update. Curr Opin Rheumatol 16: 588-594.
Noria A, Zen M, Bestio S (2012): Autoinflammation and autoimmunity: bridging the divide. Autoimmun Rev 12: 22-30.
Lin YT, Wang CT, Gershwin ME, Chiang BL (2011): The pathogenesis of oligoarticular/polyarticular vs systemic juvenile idiopathic arthritis. Autoimmun Rev 10: 482-489.
Correll CK, Binstadt BA (2014): Advances in the pathogenesis and treatment of systemic juvenile idiopathic arthritis. Pediatr Res 75: 176-183.
Ferrara N, Gerber HP, LeCouter J (2003): The biology of VEGF and its receptors. Nat Med 9: 669-679.
Neufeld G, Cohen T, Gengrinovitvh S, Poltorak Z (1999): Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13: 9-22.
Clauss M (2000): Molecular biology of the VEGF and the VEGF receptor family. Semin Thromb Hemost 26: 561-569.
Seetharam L, Gotoh N, Maru Y, et al. (1995): A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene 10: 135-147.
Kim I, Kim HG, So JN, et al. (2000): Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3’-kinase/Akt signal transduction pathway. Circ Res 86: 24-29.
Ashara T, Chen D, Takahashi T, et al. (1998): Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res 83: 233-240.
Holash J, Maisonpierre PC, Compton D, et al. (1999): Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284: 1994-1997.
Vajkoczy P, Farhadi M, Gaumann A, et al. (2002): Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2.
J Clin Invest 109: 777-778.
Koch AE (1998): Angiogenesis: implications for rheumatoid arthritis. Arthritis Rheum 41: 951-962.
Paleolog EM (2002): Angiogenesis in rheumatoid arthritis. Arthritis Res 4: 81-90.
Taylor PC, Sivakumar B (2005): Hypoxia and angiogenesis in rheumatoid arthritis. Curr Opin Rheumatol 17: 293-298.
Maruotti N, Cantatore FP, Crivellato E, et al. (2006): Angiogenesis in rheumatoid arthritis. Histol Histopathol 21: 557-566.
Ballara SC, Taylor PC, Reusch P, et al. (2001): Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis. Arthritis Rheum 44: 2055-2064.
Maruotti N, Cantatore FP, Crivellato E, et al. (2006): Angiogenesis in rheumatoid arthritis. Histol Histopathol 21: 557-566.
Vignola S, Picco P, Falcini F, et al. (2002): Serum and synovial fluid concentration of vascular endothelial growth factors in juvenile idiopathic arthritis. Rheumatology 41: 691-696.
Park CC, Morel JC, Amin MA, et al. (2001): Evidence of IL-18 as a novel angiogenic mediator. J Immunol 167: 1644-1653.
Veale DJ, Fearon U (2006): Inhibition of angiogenic pathways in rheumatoid arthritis: potential for therapeutic targeting. Best Pract Res Clin Rheumatol 20: 941-947.
Szekanecz Z, Besenyei T, Paragh G, Koch AE (2009): Angiogenesis in rheumatoid arthritis. Autoimmunity 42: 563-573.
Lainer-Carr D, Brahn E (2007): Angiogenesis inhibition as a therapeutic approach for inflammatory synovitis. Nat Clin Pract Rheumatol 3: 434-442.
Kurosaka D, Yoshida K, Yasuda J, et al. (2007): The effect of endostatin evaluated in an experimental animal model of collagen-induced arthritis. Scand J Rheumatol 36: 434-441.
Tas SW, Maracle CX, Balogh E, Szekanecz Z (2016): Targeting of proangiogenic signaling pathways in chronic inflammation. Nat Rev Rheumatol 12: 111-112.
Kitchen J, Kane D (2015): Greyscale and power Doppler ultrasonographic evaluation of normal synovial joints: correlation with pro- and anti-inflammatory cytokines and angiogenic factors. Rheumatology (Oxford) 54: 458-462.
Ramirez J, Ruiz-Esquide V, Pomés I, et al. (2014): Patients with rheumatoid arthritis in clinical remission and ultrasound-defined active synovitis exhibit higher disease activity and increased serum levels of angiogenic biomarkers. Arthritis Res Ther 16: R5.
Strunk J, Heinemann E, Neeck G, et al. (2004): A new approach to studying angiogenesis in rheumatoid arthritis by means of power Doppler ultrasonography and measurement of serum vascular endothelial growth factor. Rheumatology (Oxford) 43: 1480-1483.
Lanni S, Wood M, Ravelli A, et al. (2013): Towards a role of ultrasound in children with juvenile idiopathic arthritis. Rheumatology (Oxford) 52: 413-420.
Collado P, Jousse-Joulin S, Alcalde M, et al. (2012): Is ultrasound a validate imaging tool for the diagnosis and management of synovitis in juvenile idiopathic arthritis? A systematic literature review. Arthritis Care Res 64: 1011-1019.
Spârchez M, Fodor D, Miu N (2010): The role of Power Doppler ultrasonography in comparison with biological markers in the evaluation of disease activity in juvenile idiopathic arthritis. Med Ultrason 12: 97-103.
Magni Manzoni S, Scirè CA, Ravelli A, et al. (2013): Ultrasound-detected synovial abnormalities are frequent in clinically inactive juvenile idiopathic arthritis, but do not predict a flare of synovitis. Ann Rheum Dis 72: 223-228.
Clavel G, Bessis N, Lemeiter D, et al. (2007): Angiogenesis markers (VEGF, soluble receptor of VEGF and angiopoietin-1) in very early arthritis and their association with inflammation and joint destruction. Clin Immunol 124: 158-164.
Taylor PC (2005): Serum vascular markers and vascular imaging in assessment of rheumatoid arthritis disease activity and response to therapy. Rheumatology (Oxford) 44: 721-728.
Salvador G, Sanmarti R, Gil-Torregrosa (2006): Synovial vascular patterns and angiogenic factors expression in synovial tissue and serum of patients with rheumatoid arthritis. Rheumatology (Oxford) 45: 966-971.
Sone H, Sakauchi M, Takahashi A (2001): Elevated levels of vascular endothelial growth factor in the sera of patients with rheumatoid arthritis. Correlation with disease activity. Life Sci 69: 1861-1869.
Maeno N, Takei S, Imanaka H (1999): Increased circulating vascular endothelial growth factor is correlated with disease activity in polyarticular juvenile rheumatoid arthritis. J Rheumatol 26: 2244-2248.
Świdrowska J, Smolewski P, Stańczyk J, Smolewska E (2015): Serum angiogenesis markers and their correlation with ultrasound-detected synovitis in juvenile idiopathic arthritis. J Immunol Res 2015: 741457.
Lee SS, Joo YS, Kim WU, et al. (2001): Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis. Clin Exp Rheumatol 19: 321-324.
Shahrara S, Volin MV, Connors MA, et al. (2002): Differential expression of the angiogenic Tie receptor family in arthritic and normal synovial tissue. Arthritis Res 4: 201-208.
Kurosaka D, Hirai K, Nisioka M, et al. (2010): Clinical significance of serum levels of vascular endothelial growth factor, angiopoetin-1 and angiopoetin-2 in patients with rheumatoid arthritis. J Rheumatol 37: 1121-1128.
Sone H, Sakauchi M, Takahashi A (2001): Elevated levels of vascular endothelial growth factor in the sera of patients with rheumatoid arthritis. Correlation with disease activity. Life Sci 69: 1861-1869.
Lanni S, Wood M, Ravelli A, et al. (2013): Towards a role of ultrasound in children with juvenile idiopathic arthritis. Rheumatology (Oxford) 52: 413-420.
Rebollo-Polo M, Koujok K, Weisser C, et al. (2011): Ultrasound findings on patients with juvenile idiopathic arthritis in clinical remission. Arthritis Care Res 63: 1013-1019.
Magni-Manzoni S, Epis O, Ravelli A (2009): Comparison of clinical versus ultrasound-determine synovitis in juvenile idiopathic arthritis. Arthritis Rheum 61: 1497-1504.
Magni-Manzoni S, Mallattia C, Lani S, Ravelli A (2012): Advances and challenges in imaging in juvenile idiopathic arthritis. Nat Rev Rheumatol 8: 329-336.
Speed CA, Bearcroft PW (2002): Musculoskeletal sonography by rheumatologists: the challenges. Rheumatology 41: 241-242.
Szkudlarek M, Court-Payen M, Jacobsen S, et al. (2003): Interobserver agreement in ultrasonography of the finger and toe joints in rheumatoid arthritis. Arthritis Rheum 48: 955-962.
Scheel AK, Hermann KG, Kahler E, et al. (2005): A novel ultrasound synovitis scoring system suitable for analyzing finger joint inflammation in rheumatoid arthritis. Arthritis Rheum 2005; 52: 733-743.
Fernandes EA, Junior MR, Mitraud AS, et al. (2008): Ultrasonografia na artrite reumatoide: aplicabilidade e perspectivas. Rev Bras Reumatol 48: 25-30.
Collado P, Naredo E, Calvo C, Crespo M (2007): Assessment of the joint recesses and tendon sheaths in healthy children by high-resolution B-mode and Power Doppler sonography. Cin Exp Rheumatol 5: 915-921.
Vlad V, Micu M, Porta F, et al. (2012): Ultrasound of the hand and wrist in rheumatology. Med Ultrason 14: 42-48.
Taljanovic MS, Melville DM, Gimber LH, et al. (2015): High-resolution US of rheumatologic diseases. Radiographics 7: 2026-2048.
Spârchez M, Fodor D, Miu N (2010): The role of Power Doppler ultrasonography in comparison with biological markers in the evaluation of disease activity in juvenile idiopathic arthritis. Med Ultrason 12: 97-103.
Shanmugavel C, Sodhi KS, Sandhu MS, et al. (2008): Role of power Doppler sonography in evaluation of therapeutic response of the knee in juvenile idiopathic arthritis. Rheumatol Int 28: 573-578.
Magni Manzoni S, Scirè CA, Ravelli A, et al. (2013): Ultrasound-detected synovial abnormalities are frequent in clinically inactive juvenile idiopathic arthritis, but do not predict a flare of synovitis. Ann Rheum Dis 72: 223-228.
Strunk J, Heinemann E, Neeck G, et al. (2004): A new approach to studying angiogenesis in rheumatoid arthritis by means of power Doppler ultrasonography and measurement of serum vascular endothelial growth factor. Rheumatology (Oxford) 43: 1480-1483.
Gok M, Erdem H, Gogus F, et al. (2013): Relationship of ultrasonographic findings with synovial angiogenesis modulators in different forms of knee arthritides. Rheumatol Int 33: 879-885.
FEATURED PRODUCTS
Quick links
© 2018 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe